From: Dried blood spots PCR assays to screen congenital cytomegalovirus infection: a meta-analysis
Author [Reference] | Year | Location | Design | Total population screened | Inclusion criteria | Size of DBS used (diameter) | DBS stored temperature | Time of samples tested to collected | Type of DNA extraction | Type of PCR | Target region | Gold standard |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Barbi et al [10] | 1998 | Italy | Prospective | 205 | Universal screening | 3 disks (3mm) | UN | UN | Heat shock | Nested-PCR | UL55 | Viral isolation from saliva |
Barbi et al [8] | 2006 | Italy | Retrospective | 874 | Suspected of cCMV infection | 3 disks (3mm) | UN | UN | Heat shock | Real-time PCR | gB | Viral isolation from urine or saliva |
Binda et al [11] | 2004 | Italy | Retrospective | 195 | Suspected of cCMV infection | 3 disks (3mm) | UN | UN | modified Heat shock | Nested-PCR | gp58 | Viral isolation from urine,saliva or blood |
Boppana et al [2] | 2010 | America | Prospective | 11407 | Universal screening | 2 disks (3mm) | room temperature | 14.6±9.6days | Qiagen M48 robotic system | Single-primer Real-time PCR | gB | The DEAFF assay on the follow-up saliva/urine sample |
Boppana et al [2] | 2010 | America | Prospective | 9018 | Universal screening | 2 disks (3mm) | room temperature | 14.6±9.6days | Qiagen M48 robotic system | Two-primer Real-time PCR | gB & IE2 | The DEAFF assay on the follow-up saliva/urine sample |
Distéfano et al [24] | 2008 | Argentina | Retrospective | 145 | Compatible symptoms | UN | UN | UN | Heat shock | Nested-PCR | gB | Viral isolation from urine |
Johansson et al [22] | 1997 | Sweden | Retrospective | 31 | infants confirmed with/without cCMV and infants whose samples were stored close to the infetive ones | 25mm2 | 4°C | 12-18 years | Phenol-chloroform | PCR+hybridization test | OP1, OP2, IE1 | Viral isolation from urine |
Leruez-Ville et al [12] | 2009 | France | Retrospective | 214 | Compatible symptoms, Maternal PI | UN | UN | UN | QiAamp DNA Blood Mini kit (Qiagen) | Real-time PCR | UL123exon 4 | Urine culture/PCR |
Leruez-Ville et al [26] | 2011 | France | Prospective | 271 | Compatible symptoms, Maternal PI | whole spot (10mm) | standard conditions | After metabolic screening | QiAamp DNA Blood Mini kit (Qiagen) | Real-time PCR | UL123exon 4 | Urine sample PCR |
Paixão et al [25] | 2009 | Portuguese | Retrospective | 308 | Neonates confirmed with/without cCMV infection | UN | UN | UN | Heat shock | Nested-PCR | gp58 | Urine shell-viral culture |
Paradizˇ et al [13] | 2012 | Slovenia | Prospective | 2841 | Universal screening | 8 discs (2mm) | room temperature | 7 days | QiAamp DNA Blood Micro kit (Qiagen) | Real-time PCR | UN | Urine sample PCR |
Scanga et al [14] | 2006 | America | Retrospective | 19 | infants confirmed with/without cCMV and infants whose samples were stored close to the infetive ones | whole spot (10mm) | room temperature | 2-20 months | QiAamp DNA Blood Micro kit (Qiagen) | Real-time PCR | POL | Urine culture |
Soetens et al [16] | 2008 | Brussels | Retrospective | 67 | Universal screening | whole spot (10mm) | room temperature | 72.9±31 months (0.5-130 months) | Phenol chloroform | Conventional PCR + nested-PCR | US8 & gH | Urine culture |
Vaudry et al [15] | 2010 | Canada | Prospective | 95 | infants with VLBWs or SGA | UN | UN | about one month | MagaZorb DNA extraction Kit (Cortex Biochem) | CMV LC-real time PCR (Roche Diagnostic) | gB1, gB2 | Viral isolation from throat swabs |
Yamamoto et al [21] | 2001 | Brazil | Prospective | 332 | Universal screening | 3 disks (6mm) | -20°C | UN | Heat shock | Nested-PCR | MIE & gB/gB1 & IE | Urine sample viral culture and/or PCR |